The University of Rochester Center for Cardiovascular Research (CCVR) has recognized? the need for multi-user Facility Cores designed to furnish CCVR investigators with expertise, service and? instrumentation to enhance ongoing research programs and to facilitate new research endeavors. By meeting the? needs of the CCVR investigators in a consolidated fashion, we can be more efficient in personnel effort and in? equipment utilization and, in many cases, provide both service and research input unavailable to the individual? investigator. Accordingly, the Histology Core will provide all infrastructure and technical support to fix, embed, section,? and process animal tissues for routine staining and histomorphometry as well as such specialized methods as? immunohistochemistry and in situ hybridization (both whole mount and slide). The Core will institute a? database for slide collation and, when necessary, data interpretation. In this manner, all Project leaders will? have immediate access to data within each project, which should facilitate the planning and/or modification of? subsequent studies. The Core will also serve as a training ground for key technology transfer to each Project's? staff. For example, all of the basic science projects propose studies in the LDLR-/- mouse wherein? histomorphometry will be done to assess the effects of various transgenes on plaque area. Histomophometric? analyses require a lot of tech time, which would infringe on time needed for tissue processing and stamping to? slides. We anticipate that by transferring this technology to staff under each project, the workload within the Histology? Core facility will be lightened significantly. This has the advantage of minimizing the hiring of additional? personnel within the Histology Core, while maximizing the use of technical staff under each Project leader's direction.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL077789-02
Application #
7429100
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2006-08-01
Project End
2010-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
2
Fiscal Year
2006
Total Cost
$150,156
Indirect Cost
Name
University of Rochester
Department
Type
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Heo, Kyung-Sun; Le, Nhat-Tu; Cushman, Hannah J et al. (2015) Disturbed flow-activated p90RSK kinase accelerates atherosclerosis by inhibiting SENP2 function. J Clin Invest 125:1299-310
Heo, Kyung-Sun; Fujiwara, Keigi; Abe, Jun-ichi (2014) Shear stress and atherosclerosis. Mol Cells 37:435-40
Le, Nhat-Tu; Heo, Kyung-Sun; Takei, Yuichiro et al. (2013) A crucial role for p90RSK-mediated reduction of ERK5 transcriptional activity in endothelial dysfunction and atherosclerosis. Circulation 127:486-99
Heo, Kyung-Sun; Chang, Eugene; Takei, Yuichiro et al. (2013) Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity. Arterioscler Thromb Vasc Biol 33:321-9
Knight, W E; Yan, C (2012) Cardiac cyclic nucleotide phosphodiesterases: function, regulation, and therapeutic prospects. Horm Metab Res 44:766-75
Wang, Xiao-Qun; Nigro, Patrizia; World, Cameron et al. (2012) Thioredoxin interacting protein promotes endothelial cell inflammation in response to disturbed flow by increasing leukocyte adhesion and repressing Kruppel-like factor 2. Circ Res 110:560-8
Dhawan, Latika; Liu, Bin; Pytlak, Allison et al. (2012) Y-box binding protein 1 and RNase UK114 mediate monocyte chemoattractant protein 1 mRNA stability in vascular smooth muscle cells. Mol Cell Biol 32:3768-75
Lim, Jae Hyang; Jono, Hirofumi; Komatsu, Kensei et al. (2012) CYLD negatively regulates transforming growth factor-?-signalling via deubiquitinating Akt. Nat Commun 3:771
Cai, Yujun; Knight, Walter E; Guo, Shujie et al. (2012) Vinpocetine suppresses pathological vascular remodeling by inhibiting vascular smooth muscle cell proliferation and migration. J Pharmacol Exp Ther 343:479-88
Le, Nhat-Tu; Takei, Yuichiro; Shishido, Tetsuro et al. (2012) p90RSK targets the ERK5-CHIP ubiquitin E3 ligase activity in diabetic hearts and promotes cardiac apoptosis and dysfunction. Circ Res 110:536-50

Showing the most recent 10 out of 50 publications